Iris Acquisition Corp. II Announces Publication of Unqualified Independent Audit Report

Liminatus Pharma +3.64% Pre

Liminatus Pharma

LIMN

0.24

0.24

+3.64%

+1.24% Pre

Iris Acquisition Corp. II has announced the release of its independent audit report. The report covers the financial statements as of February 4, 2026, and is an unqualified opinion issued by KNAV CPA LLP. The full report can be accessed through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iris Acquisition Corp. II published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001185185-26-000487), on February 10, 2026, and is solely responsible for the information contained therein.

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via